RGNX

NASDAQ · Equity

Regenxbio Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
7.010000
Fair value
12.465256
Expectation
Negative 42.51%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
7.01
12-Week Change
-18.20%
Trend Signal
Inactive
Expectation
Negative 42.51%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-43.18
Market Dynamics
0.13

Over the latest 12 completed weeks ending 2026-05-29, RGNX fell 18.20%, moving from 8.57 to 7.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -43.18 and has softened across the 12-week window. Market Dynamics is 0.13 on the latest week. Expectation is negative at 42.51%.